Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts

Haematologica

Volumn 88, Issue 11, 2003, Pages 1221-1228

  Martinelli, Giovanni ^a,d   Ottaviani, Emanuela ^a   Buonamici, Silvia ^a,b   Isidori, Alessandro ^a   Borsaru, Gabriela ^a   Visani, Giuseppe ^c   Piccaluga, Pier Paolo ^a   Malagola, Michele ^a   Testoni, Nicoletta ^a   Rondoni, Michela ^a   Nucifora, Giuseppina ^c   Tura, Sante ^a   Baccarani, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Department of Hematology ^*

^d Inst Hematol/Med Oncol Seragnoli   (Italy)

Author keywords

3q21q26 syndrome; AML; PR domain; RPN1 EVI1

Indexed keywords

3Q21Q26 SYNDROME; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHROMOSOME DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; EV1 GENE; EVALUATION; FEMALE; FUSION GENE; GENE EXPRESSION; GENE FUSION; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPE; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RPN1 GENE;

ADULT; AMINO ACID SEQUENCE; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW; CHROMOSOMES, HUMAN, PAIR 3; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INVERSION, CHROMOSOME; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ALIGNMENT; SYNDROME; THROMBOCYTOPENIA; TRANSLOCATION, GENETIC;

EID: 10744221858     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bitter MA, Neilly ME, Le Beau MM, Pearson MG, Rowley JD. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1985;66:1362-70
2. Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica 1999;84:690-4.
3. Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, et al. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 1990;76:2594-8.
4. Bernstein R, Bagg A, Pinto M, Lewis D, Mendelow B. Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia. Blood 1986;68:652-7.
5. Rowley JD, Potter D. Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976;47:705-21.
6. Mitelman F, Heim S. Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer 1992;5:57-66.
7. Grigg AP, Gascoyne RD, Phillips GL, Horsman DE. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993;83:158-65.
8. Barjesteh van Waalwijk S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003;101:837-45.
9. Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3; 3)(q21;q26). Leukemia 1994;8:1318-26.
10. Secker-Walker LM, Mehta A, Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 1995;91:490-501.
11. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988;54:831-40.
12. Bartholomew C, Ihle JN. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol 1991;11:1820-8.
13. Morishita K, Parganas E, Parham DM, Matsugi T, Ihle JN. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene 1990;5:1419-23.
14. Perkins AS, Mercer JA, Jenkins NA, Copeland NG. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development 1991;111:479-87.
15. Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, et al. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 1994;84:2681-8.
16. Nucifora G. The EVI1 gene in myeloid leukemia. Leukemia 1997;11:2022-31.
17. Kreider BL, Orkin SH, Ihle JN. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc Natl Acad Sci USA 1993;90:6454-8
18. Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 1992;89:3937-41.
19. Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia. Cancer Res 1997;57:3914-9.
20. Fears S, Mathieu C, Zeleznik-Le N, Huang S, Rowley JD, Nucifora G. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci USA 1996;93:1642-7.
21. Turner CA Jr, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 1994;77:297-306.
22. Huang S, Shao G, Liu L. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998;273:15933-9.
23. Buyse IM, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 1995;92:4467-71.
24. Nishikata I, Sasaki H, Iga M, Tateno Y, Imayoshi S, Asoh N, et al. A novel EVI1 gene family, MEL1 lacking a PR domain (MEL1S) is mainly expressed in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003;(in press).
25. Gyory I, Fejer G, Ghosh N, Seto E, Wright KL. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol 2003;170:3125-33.
26. Soderholm J, Kobayashi H, Mathieu C, Rowley JD, Nucifora G. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia 1997;11:352-8.
27. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-8.
28. Testoni N, Lemoli RM, Martinelli G, Carboni C, Pelliconi S, Ottaviani E, et al. Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods. Bone Marrow Transplant 1998;22:1065-70.
29. An International System for Human Cytogenetic Nomenclature (1985) ISCN 1985. Report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig Artic Ser 1985;21:1-117.
30. Testoni N, Martinelli G, Farabegoli P, Zaccaria A, Amabile M, Raspadori D, et al. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients. Blood 1996;87:3822-7.
31. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-28.
32. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 1994;91:4004-8.
33. Russell M, List A, Greenberg P, Woodward S, Ginsmann B, Parganas E, et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 1994;84:1243-8.
34. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, Copeland NG, et al. Retroviral insertions in the CB1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene. 1989;4:529-34.
35. Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G, Reuter G. The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. Embo J. 1994;13:3822-31.
36. Jenuwein T, Laible G, Dorn R, Reuter G. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell Mol Life Sci 1998;54:80-93.